Search

Jun H Zhao

from Westfield, NJ
Age ~56

Jun Zhao Phones & Addresses

  • 6 Lambert Cir, Westfield, NJ 07090 (908) 340-9608
  • 1141 Mount Vernon Ave APT 119, Lake Forest, IL 60045
  • Lake Bluff, IL
  • Livingston, NJ
  • Millburn, NJ
  • 488 Westgate Dr, Edison, NJ 08820 (908) 753-9965
  • Piscataway, NJ
  • Springfield, NJ

Work

Company: Jun zhao Address: 490 Union Ave Apt B3, Roseland, NJ 07068 Phones: (212) 681-3117 Position: Executive officer Industries: Legal Services

Professional Records

Lawyers & Attorneys

Jun Zhao Photo 1

Jun Zhao - Lawyer

View page
ISLN:
923711244
Admitted:
2006

Medicine Doctors

Jun Zhao Photo 2

Jun Zhao

View page
Specialties:
Neurology
Work:
Riverside Medical GroupRiverside Neurology Specialists
12200 Warwick Blvd STE 110, Newport News, VA 23601
(757) 534-5100 (phone), (757) 534-5395 (fax)

Riverside Medical GroupRiverside Hampton Roads Neurology
850 Enterprise Pkwy STE 1400, Hampton, VA 23666
(757) 637-7500 (phone), (757) 637-7541 (fax)
Procedures:
Neurological Testing
Sleep and EEG Testing
Lumbar Puncture
Conditions:
Alzheimer's Disease
Carpel Tunnel Syndrome
Dementia
Epilepsy
Hemorrhagic stroke
Languages:
English
Description:
Dr. Zhao works in Hampton, VA and 1 other location and specializes in Neurology. Dr. Zhao is affiliated with Riverside Regional Medical Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jun Zhao
Executive Officer
Jun Zhao
Legal Services
490 Union Ave Apt B3, Roseland, NJ 07068
Jun Jie Zhao
SUN KELLY INC
Nonclassifiable Establishments
279 Mckibbin St, Brooklyn, NY 11206
53 Nemahan St 2 Flr, Brooklyn, NY 11221
279 Mckibben St, Brooklyn, NY 11206
53 Menahan St, Brooklyn, NY 11221
Jun Zhao
Executive Officer
Jun Zhao
Legal Services
490 Union Ave Apt B3, Roseland, NJ 07068

Publications

Us Patents

Methods

View page
US Patent:
8183266, May 22, 2012
Filed:
Jun 4, 2008
Appl. No.:
12/663114
Inventors:
Lawrence P. Wennogle - New York NY, US
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/44
A61K 31/4406
C07D 213/69
C07D 213/68
C07D 213/61
A61P 25/22
US Classification:
514348, 514349, 514351, 546296, 546297, 546300
Abstract:
The invention relates to the novel chemical compounds of the formula (I): (I) in free or salt form, its use in the treatment of NET and/or SERT mediated conditions, e. g. , depression, vasomotor symptoms, e. g. , hot flashes and other diseases or conditions mediated by NET and/or SERT.

Organic Compounds

View page
US Patent:
8536159, Sep 17, 2013
Filed:
Dec 7, 2009
Appl. No.:
13/133033
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565
A61K 31/519
A61K 31/57
C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 3-(thio, sulfonyl or sulfonyl)-7,8-dihydro-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or a substituted 3-(thio, sulfinyl or sulfonyl)-7,8,9-trihydro-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

View page
US Patent:
8633180, Jan 21, 2014
Filed:
Dec 7, 2009
Appl. No.:
13/133082
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565
A61K 31/57
A61K 31/519
C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

View page
US Patent:
20110281832, Nov 17, 2011
Filed:
Dec 7, 2009
Appl. No.:
13/133096
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
International Classification:
A61K 31/565
A61K 31/519
A61K 31/57
A61P 25/16
A61P 25/14
A61P 25/28
A61P 25/24
A61P 25/00
A61P 25/22
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 11/00
A61P 11/02
A61P 29/00
A61P 37/06
A61P 43/00
A61P 5/14
A61P 15/06
A61P 15/08
A61P 19/10
A61P 35/00
A61P 27/06
A61P 25/18
C07D 487/04
US Classification:
514171, 544262, 5142621
Abstract:
Optionally substituted (5- or 7-amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

View page
US Patent:
20120094966, Apr 19, 2012
Filed:
Dec 7, 2009
Appl. No.:
13/132955
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence Wennogle - New York NY, US
International Classification:
A61K 31/519
A61K 31/565
A61K 31/57
A61P 25/16
A61P 25/14
A61P 25/28
A61P 25/24
A61P 25/00
A61P 25/22
A61P 25/18
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 11/00
A61P 11/02
A61P 37/06
A61P 29/00
A61P 15/12
A61P 5/14
A61P 15/08
A61P 19/10
A61P 13/08
A61P 35/00
A61P 43/00
A61P 27/06
A61P 27/02
C07D 487/04
US Classification:
514171, 544262, 5142621
Abstract:
The present invention relates to optionally substituted 3-amino-4,5-dihydro-(1H or 2H)-pyrazolo[3,4-d]pyrimidin-6(7H)-ones and their 4-imino or 4-thioxo derivatives, e.g., 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

View page
US Patent:
20120136013, May 31, 2012
Filed:
Dec 7, 2009
Appl. No.:
13/133147
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
International Classification:
A61K 31/519
A61P 25/16
A61P 25/00
A61P 25/24
A61P 25/28
A61P 25/22
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 29/00
A61P 37/08
A61P 19/10
A61P 15/06
A61P 27/06
A61P 25/18
C07D 487/04
US Classification:
5142651, 544280
Abstract:
Optionally substituted (5- or 7-amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Phosphodiesterase 1-Targeting Tracers And Methods

View page
US Patent:
20120201754, Aug 9, 2012
Filed:
Oct 7, 2010
Appl. No.:
13/500941
Inventors:
Peng Li - New York NY, US
Lawrence P. Wennogle - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
International Classification:
A61K 51/04
A61P 25/00
A61P 9/00
C07D 473/06
A61P 9/12
US Classification:
424 189, 544266, 424 165, 424 185, 424 181
Abstract:
Tracers targeting phosphodiesterase 1 for use in gamma radiation detection-based diagnostic techniques, particulaly gamma-emitter labeled tracers for SPECT and positron emitter-labeled compositions for PET are disclosed. Radio-labeled multiple novel scaffolds as PDE1 inhibitors such as substituted pyrazolo-pyrimidin-4-one derivatives, biomarkers for phosphodiesterase 1 [PDE1) in vivo, methods for developing novel therapies for PDE1-implicated conditions such as pulmonary arterial hypertension (PAH), Central Nervous System (CNS) and Cardiovascular (CV) disorders, and methods of detection and treatment are also disclosed.

Organic Compounds

View page
US Patent:
20130085123, Apr 4, 2013
Filed:
May 31, 2011
Appl. No.:
13/701235
Inventors:
Peng Li - New York NY, US
Hailin Zheng - New York NY, US
Jun Zhao - New York NY, US
Lawrence P. Wennogle - New York NY, US
Assignee:
INTRA-CELLULAR THERAPIES, INC. - New York NY
International Classification:
C07D 487/14
A61K 45/06
A61K 31/557
A61K 31/19
A61K 31/565
A61K 31/573
A61K 31/519
A61K 31/165
US Classification:
514171, 544247, 514257, 544251, 514267
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Jun H Zhao from Westfield, NJ, age ~56 Get Report